These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22876985)

  • 1. Public vaccination policy using an age-structured model of pneumococcal infection dynamics.
    Sutton KL; Banks HT; Castillo-Chavez C
    J Biol Dyn; 2010 Mar; 4(2):176-95. PubMed ID: 22876985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populations.
    Snedecor SJ; Strutton DR; Ciuryla V; Schwartz EJ; Botteman MF
    Vaccine; 2009 Jul; 27(34):4694-703. PubMed ID: 19520197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.
    Taitel M; Cohen E; Duncan I; Pegus C
    Vaccine; 2011 Oct; 29(45):8073-6. PubMed ID: 21864625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P; Black S; Borrow R; Pearce D
    Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
    Ingels H; Rasmussen J; Andersen PH; Harboe ZB; Glismann S; Konradsen H; Hoffmann S; Valentiner-Branth P; Lambertsen L;
    Vaccine; 2012 Jun; 30(26):3944-50. PubMed ID: 22504662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
    Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
    Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy.
    Ansaldi F; de Florentiis D; Canepa P; Zancolli M; Martini M; Orsi A; Durando P; Icardi G
    Vaccine; 2012 Mar; 30(13):2288-94. PubMed ID: 22306795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
    Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
    Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).
    Díez-Domingo J; Ridao-López M; Gutiérrez-Gimeno MV; Puig-Barberá J; Lluch-Rodrigo JA; Pastor-Villalba E
    Vaccine; 2011 Dec; 29(52):9640-8. PubMed ID: 22027484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The shifting dynamics of pneumococcal invasive disease after the introduction of the pneumococcal 7-valent conjugated vaccine: toward the new pneumococcal conjugated vaccines.
    Greenberg D
    Clin Infect Dis; 2009 Jul; 49(2):213-5. PubMed ID: 19508164
    [No Abstract]   [Full Text] [Related]  

  • 12. A steady-state, population-based model to estimate the direct and indirect effects of pneumococcal vaccines.
    Talbird SE; Ismaila AS; Taylor TN
    Vaccine; 2010 Nov; 28 Suppl 6():G3-13. PubMed ID: 21075267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme.
    Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Andersen PH; Howitz M; Krogfelt KA; Lambertsen L; Konradsen HB
    Vaccine; 2010 Mar; 28(14):2642-7. PubMed ID: 20096392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
    Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy.
    Boccalini S; Azzari C; Resti M; Valleriani C; Cortimiglia M; Tiscione E; Bechini A; Bonanni P
    Vaccine; 2011 Nov; 29(51):9521-8. PubMed ID: 22008820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination against pneumococcal infection in adults].
    Viejo JL
    Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():26-8. PubMed ID: 20084346
    [No Abstract]   [Full Text] [Related]  

  • 17. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
    Tate JE; Kisakye A; Mugyenyi P; Kizza D; Odiit A; Braka F
    Vaccine; 2011 Apr; 29(17):3329-34. PubMed ID: 21241733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention.
    Bridy-Pappas AE; Margolis MB; Center KJ; Isaacman DJ
    Pharmacotherapy; 2005 Sep; 25(9):1193-212. PubMed ID: 16164394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal vaccination. Controversies and opportunities.
    Spika JS; Fedson DS; Facklam RR
    Infect Dis Clin North Am; 1990 Mar; 4(1):11-27. PubMed ID: 2407776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the response to 23-valent pneumococcal vaccine in splenectomised patients be predicted?
    Llupià A; Vilella A; Costas L; Díez C; Torres F; Yagüe J; Massó M; Muñoz A; Mensa J
    Vaccine; 2012 Mar; 30(13):2382-6. PubMed ID: 21964060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.